RSI Alert: Revance Therapeutics (RVNC) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Wednesday, shares of Revance Therapeutics Inc ( RVNC) entered into oversold territory, hitting an RSI reading of 26.4, after changing hands as low as $24.50 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 35.1. A bullish investor could look at RVNC's 26.4 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of RVNC shares:

START SLIDESHOW:
Find out what 9 other oversold stocks you need to know about »

Revance Therapeutics Inc 1 Year Performance Chart

Looking at the chart above, RVNC's low point in its 52 week range is $21.00 per share, with $39.86 as the 52 week high point — that compares with a last trade of $25.95.

More from Stocks

Stocks Loses Steam as Yields Hover Near 3% Threshold

Stocks Loses Steam as Yields Hover Near 3% Threshold

How Elon Musk Controls Tesla With Only a Minority Ownership Stake

How Elon Musk Controls Tesla With Only a Minority Ownership Stake

Tesla Is Taking Apple's Ecosystem Model Up a Notch

Tesla Is Taking Apple's Ecosystem Model Up a Notch

After Facebook, Google's Data Practices May Be Under Fire Next

After Facebook, Google's Data Practices May Be Under Fire Next

Video: Jim Cramer on What Trade Tariffs and Rising Rates Mean for Stocks

Video: Jim Cramer on What Trade Tariffs and Rising Rates Mean for Stocks